Just diagnosed with Encephalocraniocutaneous lipomatosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Encephalocraniocutaneous lipomatosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Encephalocraniocutaneous lipomatosis hub →Overview
Encephalocraniocutaneous lipomatosis is a rare condition. Also known as Haberland syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Encephalocraniocutaneous lipomatosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:2396 · OMIM 613001 · ICD-10 E88.2 · GARD 0002108
Find care for Encephalocraniocutaneous lipomatosis
Authoritative references for Encephalocraniocutaneous lipomatosis
Research & market landscape for Encephalocraniocutaneous lipomatosis
Following Encephalocraniocutaneous lipomatosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Encephalocraniocutaneous lipomatosis — the real-world landscape behind the condition, in one place.
- Latest Encephalocraniocutaneous lipomatosis research on PubMed ↗
- Recruiting Encephalocraniocutaneous lipomatosis trials on ClinicalTrials.gov ↗
- Explore the Encephalocraniocutaneous lipomatosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Encephalocraniocutaneous lipomatosis and every rare condition. See how Tomeko works with industry →
Common questions
What is Encephalocraniocutaneous lipomatosis?
Encephalocraniocutaneous lipomatosis is a rare condition. Also known as Haberland syndrome. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Encephalocraniocutaneous lipomatosis together in one place.
What are the symptoms of Encephalocraniocutaneous lipomatosis?
Symptoms of Encephalocraniocutaneous lipomatosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Encephalocraniocutaneous lipomatosis.
How is Encephalocraniocutaneous lipomatosis treated?
Treatment for Encephalocraniocutaneous lipomatosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Encephalocraniocutaneous lipomatosis, and review current options with them.
What causes Encephalocraniocutaneous lipomatosis — is it genetic?
The cause and inheritance of Encephalocraniocutaneous lipomatosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Encephalocraniocutaneous lipomatosis can explain what it means for you and your family.
I was just diagnosed with Encephalocraniocutaneous lipomatosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Encephalocraniocutaneous lipomatosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Encephalocraniocutaneous lipomatosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Encephalocraniocutaneous lipomatosis, filtered to your area.
Are there clinical trials for Encephalocraniocutaneous lipomatosis?
Tomeko shows live, recruiting studies for Encephalocraniocutaneous lipomatosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3